Ocugen Inc. (NASDAQ: OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech’s COVID-19 vaccine Covaxin, for children between the ages of 2 and 18.
Exscientia, the U.K.-based artificial intelligence-driven pharmatech firm, submitted its F-1 on Friday, penciling an initial $100 million estimated proceeds. The…